lobular carcinoma in situ
Showing 1 - 4 of 4
BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)
Not yet recruiting
- BRCA Mutation
- +3 more
- Tamoxifen 10 Mg Tablet
- +2 more
-
Genoa, Italy
- +3 more
Sep 11, 2023
Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each
Recruiting
- Atypical Hyperplasia
- Lobular Carcinoma in Situ
- Tamoxifen
- +2 more
-
Evanston, Illinois
- +1 more
Jan 20, 2023
Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ Trial in Boston (Naltrexone, Sugar
Terminated
- Invasive Breast Cancer (Stage I-III)
- +4 more
- Naltrexone
- Sugar Pill
-
Boston, Massachusetts
- +1 more
Nov 12, 2021
Atypical Lobular Hyperplasia, Atypical Ductal Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Molecular Breast
Completed
- Atypical Lobular Hyperplasia
- +2 more
- Molecular Breast Imaging
- Screening Mammography
-
Rochester, MinnesotaMayo Clinic
Oct 6, 2016